APA

van Rhee F., Szmania S. M., Dillon M., van Abbema A. M., Li X., Stone M. K., Garg T. K., Shi J., Moreno-Bost A. M., Yun R., Balasa B., Ganguly B., Chao D., Rice A. G., Zhan F., Shaughnessy J. D., Barlogie B., Yaccoby S. & Afar D. E. H. (20100105). Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma. : Molecular cancer therapeutics.

Chicago

van Rhee Frits, Szmania Susann M, Dillon Myles, van Abbema Anne M, Li Xin, Stone Mary K, Garg Tarun K, Shi JuMei, Moreno-Bost Amberly M, Yun Rui, Balasa Balaji, Ganguly Bishwa, Chao Debra, Rice Audie G, Zhan Fenghuang, Shaughnessy John D, Barlogie Bart, Yaccoby Shmuel and Afar Daniel E H. 20100105. Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma. : Molecular cancer therapeutics.

Harvard

van Rhee F., Szmania S. M., Dillon M., van Abbema A. M., Li X., Stone M. K., Garg T. K., Shi J., Moreno-Bost A. M., Yun R., Balasa B., Ganguly B., Chao D., Rice A. G., Zhan F., Shaughnessy J. D., Barlogie B., Yaccoby S. and Afar D. E. H. (20100105). Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma. : Molecular cancer therapeutics.

MLA

van Rhee Frits, Szmania Susann M, Dillon Myles, van Abbema Anne M, Li Xin, Stone Mary K, Garg Tarun K, Shi JuMei, Moreno-Bost Amberly M, Yun Rui, Balasa Balaji, Ganguly Bishwa, Chao Debra, Rice Audie G, Zhan Fenghuang, Shaughnessy John D, Barlogie Bart, Yaccoby Shmuel and Afar Daniel E H. Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma. : Molecular cancer therapeutics. 20100105.